Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 1, 2012, Pages 151-155

  Coviello, V ^a   Peluso, F ^b   Dehkhargani, S Z ^a   Verdugo, F ^c   Raffaelli, L ^a   Manicone, P F ^a   D'Addona, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b AORN Sant' Anna and San Sebastiano   (Italy)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bisphosphonates; Multiple myeloma; Osteonecrosis of the jaw; Platelet rich plasma

Indexed keywords

PAMIDRONIC ACID; ZOLEDRONIC ACID;

ABSCESS; AGED; ARTICLE; CLINICAL ARTICLE; DEBRIDEMENT; DISEASE COURSE; FEMALE; FOLLOW UP; FRACTURE HEALING; HUMAN; JAW OSTEONECROSIS; MALE; MANDIBLE; MANDIBLE RESECTION; MULTIPLE MYELOMA; ORTHOPEDIC SURGERY; OSTEOLYSIS; POSTOPERATIVE PERIOD; SEQUESTROTOMY; SKIN FISTULA; THROMBOCYTE RICH PLASMA; TOOTH EXTRACTION; WOUND HEALING;

AGED; AGED, 80 AND OVER; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BLOOD TRANSFUSION, AUTOLOGOUS; DIPHOSPHONATES; HUMANS; IMIDAZOLES; MULTIPLE MYELOMA; PLATELET-RICH PLASMA; TOOTH EXTRACTION; WOUND HEALING;

EID: 84859885270     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 2005; 34:613-7. (Pubitemid 41512948)
2. Marx RE. Pamidronate (AREDIA) and Zoledronate (ZOMETA) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61:1115-8.
3. Ruggiero S, Mehrotra B, Rosenberg T, Engroff S. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62:52-34.
4. Statz TA, Guthmiller JM, Humbert LA, Johnson GK. Intravenous bisphosphonate-associated osteonecrosis of the jaw. J Periodontol 2007; 78:2203-8.
5. Silverman SL et al. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med 2009; 122:33-45.
6. Raffaelli L, Scaramuzzo L, Rossi Iommetti P, Graci C, Maccauro G, Manicone PF. Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis. J Biol Regul Homeost Agents 2010; 24:115-21.
7. Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab 2009; 27:435-43.
8. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol 2006; 24:945-52. (Pubitemid 46638849)
9. Curi MM, Cossolin GS, Koga DH, Araujo SR, Feher O, dos Santos MO, Zardetto C. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases. J Oral Maxillofac Surg 2007; 65:349-55. (Pubitemid 46131421)
10. Hoff AO, Toth BB, Altundag K, et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 2008; 23:826-36. (Pubitemid 351768801)
11. Jadu F, Lee L, Pharoah M, et al. A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol 2007; 18:2015-9. (Pubitemid 350286242)
12. Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L, Blum C, Grötz KA, Wagner W. Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med 2010; 6:11.
13. Terpos E, Sezer O, Croucher PI, et al. European Myeloma Network. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network. Ann Oncol 2009; 20:1303-17.
14. Dimitrakopoulos I, Magopoulos C, Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg 2006; 35:588-93. (Pubitemid 43863136)
15. Ruggiero SL, Thomas B, Dodson, Leon A. Assael, Regina Landesberg, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws - 2009 Update. J Oral Maxillofac Surg 2009; 67:2-12.
16. Oyama T, Nishimoto S, Tsugawa T, Shimizu F. Efficacy of platelet-rich plasma in alveolar bone grafting. J Oral Maxillofac Surg 2004; 62:555-8. (Pubitemid 38542520)
17. Lee CY, David T, Nishime M. Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 2007; 33:371-82.
18. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62:489-96. (Pubitemid 38451232)
19. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:638-46. (Pubitemid 128641964)